| Customization: | Available |
|---|---|
| Package: | 3*10tablets/Box |
| Composition: | Lamotrigine |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product | Dose | Package |
| Lamotrigine Extended-Release Tablets | 200mg | 3*10Tablets/box |
Lamotrigine Extended-Release Tablets are a pharmaceutical formulation designed to provide sustained release of lamotrigine, a medication used in the management of epilepsy and bipolar disorder. This extended-release version offers the convenience of once-daily dosing while providing continuous therapeutic levels of the drug over a prolonged period.
Epilepsy: Lamotrigine Extended-Release Tablets are indicated for the treatment of various types of seizures in adults and children with epilepsy, including partial seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome.
Bipolar Disorder: Additionally, lamotrigine is used as a maintenance treatment for bipolar disorder to prevent the recurrence of mood episodes, including depression, mania, and hypomania, in adult patients.
Lamotrigine Extended-Release Tablets are taken orally with water, typically once daily. The dosage and titration schedule are individualized based on factors such as the patient's age, weight, renal function, and concurrent medications.
It is important to follow the prescribed dosing regimen and titration schedule to minimize the risk of side effects, particularly skin rash, which can be a serious adverse reaction associated with lamotrigine use.
Safety and Considerations:
Patients should be monitored closely for signs of hypersensitivity reactions, including skin rash, during treatment initiation and dose escalation. Immediate medical attention is necessary if a rash develops, as it may progress to severe dermatological conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis.
Lamotrigine therapy should be managed cautiously in patients with a history of mood disorders or suicidal ideation, as it may affect mood and behavior.
){kind=link}